Clicky

Tuesday, November 17, 2026

Earnings

Results and financial condition

Unity Software reports record Q3 results with GAAP profit

Unity Software Inc. announces record financial results for Q3 2026, achieving GAAP profitability for the first time since its IPO.

Middleby Corp reports strong Q3 results, announces CEO change

Middleby Corp exceeds Q3 expectations, raises guidance, and announces CEO transition. Strong performance noted in the refrigeration machinery sector.

Amylyx Pharmaceuticals announces Q3 2026 financial results

Amylyx Pharmaceuticals reveals its financial results for Q3 2026, showcasing its position in the pharmaceutical preparations industry.

Shake Shack Reports Strong Q3 2026 Financial Results

Shake Shack Inc. announces robust financial results for Q3 2026, highlighting revenue growth and increased profitability, impacting investor confidence.

Frontdoor reports third-quarter results for 2026

Frontdoor, Inc. announces its financial results for Q3 2026, highlighting key operational metrics and industry implications.

Rockwell Automation Reports Strong Q4 and FY 2026 Results

Rockwell Automation announces fourth-quarter and full-year 2026 financial results, showcasing significant growth in sales and earnings.

Apyx Medical reports strong Q3 results, reaffirms guidance

Apyx Medical Corp announces strong Q3 results with $14 million in revenue, driven by growth in its Surgical Aesthetics segment and a successful product launch.

Shift4 Payments reports Q3 2026 financial results

Shift4 Payments, Inc. announces its Q3 2026 financial results, showcasing growth strategies and market expansion plans.

Cartesian Therapeutics reports Q3 2026 results, pipeline advances

Cartesian Therapeutics announces Q3 2026 financial results, highlighting progress in its pipeline and upcoming data readouts for Descartes-08 therapy.

Global Payments reports strong Q3 results, raises synergy outlook

Global Payments Inc. announces strong Q3 2026 results, with increased earnings and revenue, and raises expectations for Worldpay integration synergies.

Lexicon Pharmaceuticals reports Q3 2026 financial results

Lexicon Pharmaceuticals shares Q3 2026 financial results, highlighting advancements in its clinical pipeline, particularly in cardiometabolic treatments.

Monte Rosa Therapeutics announces Q3 2026 financial results

Monte Rosa Therapeutics released its financial results for Q3 2026, providing insights into its operational performance and future strategies.

Nexstar Media Group reports strong Q3 2026 financial results

Nexstar Media Group announces its third-quarter financial results for 2026, showcasing significant revenue growth in the television broadcasting sector.

1-800-FLOWERS.COM Reports Fiscal 2027 First Quarter Results

1-800-FLOWERS.COM, Inc. announces fiscal 2027 Q1 results, showing revenue decline and net loss as it focuses on website improvements and capital structure.

Bentley Systems Reports Strong Q3 2026 Financial Results

Bentley Systems, Inc. announces robust financial results for Q3 2026, highlighting significant revenue growth and improved profit margins.

Fate Therapeutics reports Q3 2026 financial results

Fate Therapeutics, Inc. announces its financial results for Q3 2026, showcasing developments in its operations and their implications for the biological products industry.

BlackSky Technology Reports Record Q3 Revenue and Profit

BlackSky Technology Inc. announces record revenue of $43 million for Q3 2026, a 118% increase year-over-year, and raises full-year guidance.

Malibu Boats reports strong Q3 results with rising sales

Malibu Boats, Inc. announces Q3 2026 financial results, showing a 29.9% increase in sales and a shift to profitability, reflecting positive industry trends.

Entrada Therapeutics reports Q3 results, updates on clinical trials

Entrada Therapeutics shares Q3 financial results and updates on clinical trials for neuromuscular diseases, including Duchenne muscular dystrophy.

Korro Bio, Inc. terminates collaboration with Novo Nordisk

Korro Bio, Inc. has announced the termination of its collaboration agreement with Novo Nordisk, effective February 1, 2027, impacting its strategic direction.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →